Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.01
-0.17 (-0.60%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
32
33
Next >
Pfizer to Provide the United Kingdom an Additional 2.5 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
December 22, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer’s VYNDAQEL®/VYNDAMAX® Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data Demonstrate
December 20, 2021
From
Pfizer Inc.
Via
Business Wire
Watch for Continued Gains in Shares of Pfizer Inc. (PFE)
December 20, 2021
Via
Investor Brand Network
Exposures
COVID-19
Pfizer Inc. (PFE) Climbs to Annual-High Share Price
December 15, 2021
Via
Investor Brand Network
Oncology Drugs Market Comprehensive Study Explore Huge Growth in Future
December 03, 2021
Stay up-to-date with Oncology Drugs Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
COVID-19
Big Data in the Healthcare & Pharmaceutical Market Is Going to Boom : Bayer, Pfizer, Novartis
November 24, 2021
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Big Data in the...
Via
SBWire
Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply
December 20, 2021
From
Pfizer Inc.
Via
Business Wire
EMA Issues Advice for Potential Early Use of Pfizer’s Novel COVID-19 Oral Antiviral Candidate
December 16, 2021
From
Pfizer Inc.
Via
Business Wire
U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing Spondylitis
December 14, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
December 14, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer to Acquire Arena Pharmaceuticals
December 13, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy
December 12, 2021
From
Sangamo Therapeutics, Inc.
Via
Business Wire
Pfizer Declares First-Quarter 2022 Dividend
December 10, 2021
From
Pfizer Inc.
Via
Business Wire
European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
December 10, 2021
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
December 09, 2021
From
Pfizer Inc.
Via
Business Wire
Kamoa-Kakula Phase 2 Expansion Now 70% Complete, on Track for Early Start-up in Q2 2022
December 09, 2021
Record copper production in November tops 18,270 tonnes, bringing year-to-date production to more than 87,000 tonnes as at November 30,...
Via
Newsfile
Topics
Emissions
Exposures
COVID-19
Pfizer and BioNTech Provide Update on Omicron Variant
December 08, 2021
From
Pfizer Inc.
Via
Business Wire
Super Generic Drugs Market to See Major Growth by 2027 : Lupin, Apotex, Sanofi, Aurobindo, Dr.Reddy's
December 09, 2021
Get an extensive Super Generic Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Topics
Supply Chain
Exposures
Supply Chain
CityHealth Opens Vaccination Program at Las Positas College in Livermore, California
December 07, 2021
Vaccinations and Booster Shots Now Available to Students and Alameda County Residents
Via
Newswire.com
Exposures
COVID-19
Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate
December 07, 2021
From
Pfizer Inc.
Via
Business Wire
Biotech Sector’s Response to Omicron Panic Should be Swift and Effective
December 07, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC – December 7, 2021 – USA News Group – Despite a level of panic that JP Morgan has already downplayed in its 2022 forecasts, the...
Via
FinancialNewsMedia
Exposures
COVID-19
Now Is the Time to Be Vaccinated for COVID-19 and Flu to Be Protected for the Holidays
November 30, 2021
This press release was orginally distributed by ReleaseWire
Via
ReleaseWire
Exposures
COVID-19
Product Safety
AI for Pharma and Biotech Market Next Big Thing : Major Giants Atomwise, CloudMedX, Roche
December 02, 2021
Stay up-to-date with AI for Pharma and Biotech Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Pediatric Drugs and Vaccines Market SWOT Analysis by Roche, Abbott Laboratories, Amgen
November 30, 2021
Stay up-to-date with Pediatric Drugs and Vaccines Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
COVID-19
BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung Cancer
November 30, 2021
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark")...
Via
Newsfile
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 24, 2021
From
Pfizer Inc.
Via
Business Wire
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
November 22, 2021
From
Pfizer Inc.
Via
Business Wire
Consumer Healthcare Products Market to Witness Huge Growth by 2026: Sanofi, Mylan, Johnson & Johnson
November 26, 2021
Stay up-to-date with Consumer Healthcare Products Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
COVID-19
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
November 19, 2021
From
Pfizer Inc.
Via
Business Wire
Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients
November 19, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Death
Intellectual Property
Supply Chain
Exposures
COVID-19
Death
Intellectual Property
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.